SEARCH

SEARCH BY CITATION

References

  • 1
    World Health Organization. WHO consultation on the development of a comprehensive approach for the prevention and control of chronic respiratory diseases. January 11–13, 2001. Management of Noncommunicable Diseases Department. Chronic Respiratory Diseases and Arthritis. WHO/NMH/CRA/01.1. Geneva: WHO, 2001.
  • 2
    Starfield B. Improving equity in health: a research agenda. Int J Health Serv 2001;31: 545566.
  • 3
    Yach D. The use and value of qualitative methods in health research in developing countries. Soc Sci Med 1992;35: 603612.
  • 4
    CCMRC/GINA. Workshop on asthma management and prevention in the Caribbean July 1–3, 1997. Trinidad. Commonwealth Caribbean Medical Research Council. Global Initiative for Asthma. West Indian Med J 1998;47: 133152.
  • 5
    Aït-Khaled N, Chaulet P, Enarsson D, Slama K. Epidemiology and management of stable chronic obstructive pulmonary disease in Africa. In: Similowski, T, Derenne, P, editors. Clinical Management of Chronic Obstructive Pulmonary Disease. New York: Marcel Dekker 2002, 10071030.
  • 6
    Lalloo UG, Bateman ED, Feldman C, et al. South African Pulmonology Society Adult Asthma Working Group. Guideline for the management of chronic asthma in adults—2000 update. S Afr Med J 2000;90: 544552.
  • 7
    Motala C, Kling S, Gie R, et al. Allergy Society of South Africa Working Group. Guideline for the management of chronic asthma in children—2000 update. S Afr Medical J 2000;90: 524528, 530, 532.
  • 8
    Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Org 1994;72: 429445.
  • 9
    Loomes G, McKenzie L. The use of QALYs in health care decision making. Soc Sci Med 1989;28: 299308.
  • 10
    Elbasha EH. Discrete time representation of the formula for calculating DALYs. Health Econ 2000;9: 353365.
  • 11
    Murray CJ, Lopez AD. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease Study. Lancet 1997;349: 13471352.
  • 12
    Arnesen T, Nord E. The value of DALY life: problems with ethics and validity of disability adjusted life years. Bmj 1999;319: 14231425.
  • 13
    Cohen J. The Global Burden of Disease Study: a useful projection of future global health? J Public Health Med 2000;22: 518524.
  • 14
    Murray CJ, Lopez AD. Mortality by cause for eight regions of the world. Global Burden Dis Study Lancet 1997;349: 12691276.
  • 15
    Cooper RS, Rotimi C, Kaufman J, Lawoyin T. Mortality data for sub-Saharan Africa. Lancet 1998;351: 17391740.
  • 16
    Kaufman JS, Asuzu MC, Rotimi CN, Johnson OO, Owoaje EE, Cooper RS. The absence of adult mortality data for sub-Saharan Africa: a practical solution. Bull World Health Org 1997;75: 389395.
  • 17
    Wurthwein R, Gbangou A, Sauerborn R, Schmidt CM. Measuring the local burden of disease. A study of years of life lost in sub-Saharan Africa. Int J Epidemiol 2001;30: 501508.
  • 18
    Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 2000;117: 1S4S.
  • 19
    Gulsvik A. The global burden and impact of chronic obstructive pulmonary disease worldwide. Monaldi Arch Chest Dis 2001;56: 261264.
  • 20
    Rahman Q, Nettesheim P, Smith KR, Seth PK, Selkirk J. International conference on environmental and occupational lung diseases. Environ Health Persp 2001;109: 425431.
  • 21
    Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163: 12561276.
  • 22
    Tanimowo MO. Air pollution and respiratory health in Africa: a review. East Afr Med J 2000;77: 7175.
  • 23
    Ellegard A. Cooking fuel smoke and respiratory symptoms among women in low-income areas in Maputo. Environ Health Persp 1996;104: 980985.
  • 24
    Ezzati M, Kammen D. Indoor air pollution from biomass combustion and acute respiratory infections in Kenya: an exposure-response study. Lancet 2001;358: 619624.
  • 25
    Bandele EO. A ten-year review of asthma deaths at the Lagos University Teaching Hospital. Afr J Med Med Sci 1996;25: 389392.
  • 26
    Rosenberg R, Vinker S, Zakut H, Kizner F, Nakar S, Kitai E. An unusually high prevalence of asthma in Ethiopian immigrants to Israel. Fam Med 1999;31: 276279.
  • 27
    Wright AL, Holberg CJ, Martinez FD, Halonen M, Morgan W, Taussig LM. Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics 1994;94: 895901.
  • 28
    Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108: S147S334.
  • 29
    Strachan D, Sibbald B, Weiland S, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997;8: 161176.
  • 30
    The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema (see comments). Lancet 1998;351: 12251232.
  • 31
    Falade AG, Olawuyi F, Osinusi K, Onadeko BO. Prevalence and severity of symptoms of asthma, allergic rhino-conjunctivitis and atopic eczema in secondary school children in Ibadan, Nigeria. East Afr Med J 1998;75: 695698.
  • 32
    Nriagu J, Robins T, Gary L, et al. Prevalence of asthma and respiratory symptoms in south-central Durban, South Africa. Eur J Epidemiol 1999;15: 747755.
  • 33
    Godfrey RC. Asthma and IgE levels in rural and urban communities of The Gambia. Clin Allergy 1975;5: 201207.
  • 34
    Van Niekerk CH, Weinberg EG, Shore SC, Heese HV, Van Schalkwyk J. Prevalence of asthma: a comparative study of urban and rural Xhosa children. Clin Allergy 1979;9: 319314.
  • 35
    Addo-Yobo EO, Custovic A, Taggart SC, Asafo-Agyei AP, Woodcock A. Exercise induced bronchospasm in Ghana: differences in prevalence between urban and rural schoolchildren. Thorax 1997;52: 161165.
  • 36
    Ng'ang'a LW, Odhiambo JA, Omwega MJ, et al. Exercise-induced bronchospasm: a pilot survey in Nairobi school children. East Afr Med J 1997;74: 694698.
  • 37
    Yemaneberhan H, Bekele Z, Venn A, Lewis S, Parry E, Britton J. Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet 1997;350: 8590.
  • 38
    Odhiambo JA, Ng'ang'a LW, Mungai MW, et al. Urban-rural differences in questionnaire-derived markers of asthma in Kenyan school children. Eur Respir J 1998;12: 11051112.
  • 39
    De Almeida MM, Pinto JR. Bronchial asthma in children: clinical and epidemiologic approach in different Portuguese speaking countries. Pediatr Pulmonol Suppl 1999;18: 4953.
  • 40
    Weinberg EG. Urbanization and childhood asthma: an African perspective. J Allergy Clin Immunol 2000;105: 224231.
  • 41
    Koffi N, Kouassi B, Ngom A, Aka-Dangui E. Value of a video questionnaire in the evaluation of the prevalence of asthma in Africa. Med Trop 2000;60: 412413.
  • 42
    Kayantao D, Toloba Y, Kamissoko M, et al. Epidemiological, clinical and progressive aspects of asthma observed at Bamako, Mali. Sante 2001;11: 101103.
  • 43
    Nyan OA, Walraven GE, Banya WA, et al. Atopy, intestinal helminth infection and total serum IgE in rural and urban adult Gambian communities. Clin Exp Allergy 2001;31: 16721678.
  • 44
    Walraven GE, Nyan OA, Van Der Sande MA, et al. Asthma, smoking and chronic cough in rural and urban adult communities in The Gambia. Clin Exp Allergy 2001;31: 16791685.
  • 45
    MacIntyre UE, De Villiers FP, Owange-Iraka JW. Increase in childhood asthma admissions in an urbanising population. S Afr Med J 2001;91: 667672.
  • 46
    Pearce N, Douwes J, Beasley R. Is allergen exposure the major primary cause of asthma? Thorax 2000;55: 424431.
  • 47
    Peat JK. The epidemiology of asthma. Curr Opin Pulm Med 1996;2: 715.
  • 48
    Kambarami RA, Marechera F, Sibanda EN, Chitiyo ME. Aero-allergen sensitisation patterns amongst atopic Zimbabwean children. Cent Afr J Med 1999;45: 144147.
  • 49
    Cadman A, Prescott R, Potter PC. Year-round housedust mite levels on the Highveld. S Afr Med J 1998;88: 15801582.
  • 50
    Woodcock A, Addo-Yobo EO, Taggart SC, Craven M, Custovic A. Pet allergen levels in homes in Ghana and the United Kingdom. J Allergy Clin Immunol 2001;108: 463465.
  • 51
    Addo-Yobo EO, Custovic A, Taggart SC, Craven M, Bonnie B, Woodcock A. Risk factors for asthma in urban Ghana. J Allergy Clin Immunol 2001;108: 363368.
  • 52
    Sunyer J, Torregrosa J, Anto J, et al. The association between atopy and asthma in a semirural area of Tanzania (East Africa). Allergy 2000;55: 762767.
  • 53
    Bousquet J. Atopy and allergy in East Africa. Allergy 2001;56: 189.
  • 54
    Costongs GM, Janson PC, Hermans WJ, Van Oers RJ, Leerkes B. Evaluation of performance characteristics of automated measurement systems for allergy testing. Eur J Clin Chem Clin Biochem 1995;33: 295305.
  • 55
    Warrell DA, Fawcett IW, Harrison BD, et al. Bronchial asthma in the Nigerian savanna region. A clinical and laboratory study of 106 patients with a review of the literature on asthma in the tropics. Q J Med 1975;44: 325347.
  • 56
    Macfarlane JT, Bachelor M, Ridyard JB, Ball PA. Asthma, IgE and environment in northern Nigeria. Clin Allergy 1979;9: 333337.
  • 57
    Joubert JR, De Klerk HC, Malan C. Ascaris lumbricoides and allergic asthma: a new perspective. S Afr Med J 1979;56: 599602.
  • 58
    Scrivener S, Yemaneberhan H, Zebenigus M, et al. Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet 2001;358: 14931499.
  • 59
    Yazdanbakhsh M, Van Den Biggelaar A, Maizels RM. Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol 2001;22: 372377.
  • 60
    Holt PG, Sly PD. Interactions between respiratory tract infections and atopy in the aetiology of asthma. Eur Respir J 2002;19: 538545.
  • 61
    Van Den Biggelaar AH, Van Ree R, Rodrigues LC, et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000;356: 17231727.
  • 62
    Holt PG. Parasites, atopy, and the hygiene hypothesis: resolution of a paradox? Lancet 2000;356: 16991701.
  • 63
    Yazdanbakhsh M, Kremsner PG, Van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002;296: 490494.
  • 64
    Scrivener S, Britton J. Immunoglobulin E and allergic disease in Africa. Clin Exp Allergy 2000;30: 304307.
  • 65
    Borkow G, Leng Q, Weisman Z, et al. Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest 2000;106: 10531060.
  • 66
    Selassie FG, Stevens RH, Cullinan P, et al. Total and specific IgE (house dust mite and intestinal helminths) in asthmatics and controls from Gondar. Ethiopia Clin Exp Allergy 2000;30: 356358.
  • 67
    Van Den Biggelaar AH, Lopuhaa C, Van Ree R, et al. The prevalence of parasite infestation and house dust mite sensitization in Gabonese schoolchildren. Int Arch Allergy Immunol 2001;126: 231238.
  • 68
    Van Ree R, Antonicelli L, Akkerdaas JH, et al. Asthma after consumption of snails in house-dust-mite-allergic patients: a case of IgE cross-reactivity. Allergy 1996;51: 387393.
  • 69
    Pascual C, Crespo J, San-Martin S, et al. Cross-reactivity between IgE-binding proteins from Anisakis, German cockroach, and chironomids. Allergy 1997;52: 514520.
  • 70
    Chua KY, Stewart GA, Thomas WR, et al. Sequence analysis of cDNA coding for a major house dust mite allergen, Der, p. 1. Homology with cysteine proteases. J Exp Med 1988;167: 175–182.
  • 71
    Michel A, Ghoneim H, Resto M, Klinkert MQ, Kunz W. Sequence, characterization and localization of a cysteine proteinase cathepsin L in Schistosoma mansoni. Mol Biochem Parasitol 1995;73: 718.
  • 72
    Van Sprundel MP. Pneumoconioses: the situation in developing countries. Exp Lung Res 1990;16: 513.
  • 73
    Rees D, Weiner R. Dust and pneumoconiosis in the South African foundry industry. S Afr Med J 1994;84: 851855.
  • 74
    Loewenson R. Assessment of the health impact of occupational risk in Africa: current situation and methodological issues. Epidemiology 1999;10: 632639.
  • 75
    Davies JC. Silicosis and tuberculosis among South African goldminers—an overview of recent studies and current issues. S Afr Med J 2001;91: 562566.
  • 76
    Yach D, Myers J, Bradshaw D, Benatar SR. A respiratory epidemiologic survey of grain mill workers in Cape Town, South Africa. Am Rev Respir Dis 1985;131: 505510.
  • 77
    Fatusi A, Erhabor G. Occupational health status of sawmill workers in Nigeria. J R Soc Health 1996;116: 232236.
  • 78
    Ige OM, Onadeko OB. Respiratory symptoms and ventilatory function of the sawmillers in Ibadan, Nigeria. Afr J Med Med Sci 2000;29: 101104.
  • 79
    Hnizdo E, Murray J, Davison A. Correlation between autopsy findings for chronic obstructive airways disease and in-life disability in South African gold miners. Int Arch Occup Environ Health 2000;73: 235244.
  • 80
    Osim EE, Tandayi M, Chinyanga HM, Matarira HT, Mudambo KK, Musabayane CT. Lung function, blood gases, pH and serum electrolytes of small-scale miners exposed to chrome ore dust on the Great Dyke in Zimbabwe. Trop Med Int Health 1999;4: 621628.
  • 81
    Osim EE, Musabayane CT, Mufunda J. Lung function of Zimbabwean farm workers exposed to flue curing and stacking of tobacco leaves. S Afr Med J 1998;88: 11271131.
  • 82
    Mengesha YA, Bekele A. Relative chronic effects of different occupational dusts on respiratory indices and health of workers in three Ethiopian factories. Am J Ind Med 1998;34: 373380.
  • 83
    Rees D, Nelson G, Kielkowski D, Wasserfall C, Da Costa A. Respiratory health and immunological profile of poultry workers. S Afr Med J 1998;88: 11101117.
  • 84
    Loewenson R. Globalization and occupational health: a perspective from southern Africa. Bull World Health Org 2001;79: 863868.
  • 85
    Ndiaye M, Fall C, Ndir M, et al. Occupational asthma in a Senegalese car sprayer. Diagnostic and medico-legal problems. Rev Mal Respir 1999;16: 199203.
  • 86
    Esterhuizen TM, Hnizdo E, Rees D, et al. Occupational respiratory diseases in South Africa—results from SORDSA, 1997–99. S Afr Med J 2001;91: 502508.
  • 87
    Hnizdo E, Esterhuizen TM, Rees D, Lalloo UG. Occupational asthma as identified by the Surveillance of Work-related and Occupational Respiratory Diseases programme in South Africa. Clin Exp Allergy 2001;31: 3239.
  • 88
    Tiendrebeogo H, Sangare SI, Roudaut M, Schmidt D, Assale N. One hundred and one cases of pulmonary aspergillosis in Ivory Coast (author's translation). Med Trop (Mars) 1982;42: 4752.
  • 89
    Mushegera CK, Mbuyi-Muamba JM, Kabemba MJ. Indications and results of pleuropulmonary decortications in the University hospital of Kinshasa. Acta Chir Belg 1996;96: 217222.
  • 90
    Desai G, Amadi W. Three years' experience of empyema thoracis in association with HIV infection. Trop Doct 2001;31: 106107.
  • 91
    Souilamas R, Riquet M, Barthes FP, Chehab A, Capuani A, Faure E. Surgical treatment of active and sequelar forms of pulmonary tuberculosis. Ann Thorac Surg 2001;71: 443447.
  • 92
    Mallory KF, Churchyard GJ, Kleinschmidt I, De Cock KM, Corbett EL. The impact of HIV infection on recurrence of tuberculosis in South African gold miners. Int J Tubercul Lung Dis 2000;4: 455462.
  • 93
    Ong RK, Doyle RL. Tropical pulmonary eosinophilia. Chest 1998;113: 16731679.
  • 94
    Morris W, Knauer CM. Cardiopulmonary manifestations of schistosomiasis. Semin Respir Infect 1997;12: 159170.
  • 95
    Bethlem EP, Schettino G, Carvalho CR. Pulmonary schistosomiasis. Curr Opin Pulm Med 1997;3: 361365.
  • 96
    Lambertucci JR, Serufo JC, Gerspacher-Lara R, et al. Schistosoma mansoni: assessment of morbidity before and after control. Acta Trop 2000;77: 101109.
  • 97
    Barbosa MM, Lamounier JA, Oliveira EC, et al. Pulmonary hypertension in Schistosoma mansoni. Trans R Soc Trop Med Hyg 1996;90: 663665.
  • 98
    Omran AR. The epidemiologic transition. A theory of the epidemiology of population change 1971. Bull World Health Org 2001;79: 161170.
  • 99
    Caldwell JC. Population health in transition. Bull World Health Org 2001;79: 159160.
  • 100
    Jamison DT, Mosley WH. Disease control priorities in developing countries: health policy responses to epidemiological change. Am J Public Health 1991;81: 1522.
  • 101
    Alberti G. Noncommunicable diseases: tomorrow's pandemics. Bull World Health Org 2001;79: 907.
  • 102
    Unwin N, Setel P, Rashid S, et al. Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? Bull World Health Org 2001;79: 947953.
  • 103
    Gill GV, Scott B, Beeching NJ, Wilkinson D, Ismail AA. Enumeration of non-communicable disease in rural South Africa by electronic data linkage and capture-recapture techniques. Trop Med Int Health 2001;6: 435441.
  • 104
    Yikona J. Non-communicable disease in sub-Saharan Africa. Lancet 2001;357: 74.
  • 105
    Yach D. Tobacco control. From concern for the lung to global political action. Thorax 2001;56: 247248.
  • 106
    World Health Organizaton. Global strategy for asthma management and prevention. WHO/NHLBI Workshop Report. Publication Number 95–3659. Bethesda: National Institutes of Health, National Heart, Lung and. Blood Institute, 1995.
  • 107
    Ait-Khaled N, Enarson D, Bousquet J. Chronic respiratory diseases in developing countries. the burden and strategies for prevention and management. Bull World Health Org 2001;79: 971979.
  • 108
    Yach D. Partnering for better lung health: improving tobacco and tuberculosis control. Int J Tubercul Lung Dis 2000;4: 693697.
  • 109
    Enarson DA, Ait-Khaled N. Cultural barriers to asthma management. Pediatr Pulmonol 1999;28: 297300.
  • 110
    Green RJ, Greenblatt MM, Plit M, Jones S, Adam B. Asthma management and perceptions in rural South Africa. Ann Allergy Asthma Immunol 2001;86: 343347.
  • 111
    Oranga HM. Ageing and poverty in rural Kenya: community perception. East Afr Med J 1997;74: 611613.
  • 112
    Yach D. Tobacco in Africa. World Health Forum 1996;17: 2936.
  • 113
    World Health Organization. Tobacco or Health: a Global Status Report. Geneva: WHO, 1997.
  • 114
    Mackay J, Crofton J. Tobacco and the developing world. Br Med Bull 1996;52: 206221.
  • 115
    Amos A. Women and smoking. Br Med Bull 1996;52: 7489.
  • 116
    Stephenson LS, Latham MC, Ottesen EA. Global malnutrition. Parasitology 2000;121: S5S22.
  • 117
    Walker AR. Nutritionally related disorders/diseases in Africans. Highlights of half a century of research with special reference to unexpected phenomena. Adv Exp Med Biol 1997;427: 114.
  • 118
    Marek T, Diallo I, Ndiaye B, Rakotosalama J. Successful contracting of prevention services. Fighting malnutrition in Senegal and Madagascar. Health Policy Plan 1999;14: 382389.
  • 119
    Vorster HH, Bourne LT, Venter CS, Oosthuizen W. Contribution of nutrition to the health transition in developing countries. a framework for research and intervention. Nutr Rev 1999;57: 341349.
  • 120
    Martin-Prevel Y, Maire B, Delpeuch F. Nutrition, urbanization and poverty in subsaharan Africa. Med Trop 2000;60: 179191.
  • 121
    The Bamako initiative. Lancet 1988;2: 11771178.
  • 122
    Chabot J. The Bamako initiative. Lancet 1988;2: 13661367.
  • 123
    Velasquez G, Boulet P. Essential drugs in the new international economic environment. Bull World Health Org 1999;77: 288292.
  • 124
    Ait-Khaled N, Auregan G, Bencharif N, et al. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. Int J Tubercul Lung Dis 2000;4: 268271.
  • 125
    Gbedonou P, Moussa Y, Floury B, Josse R, Ndiaye JM, Diallo S. The Bamako initiative: hope or illusion? Observations on the Benin experience. Sante 1994;4: 281288.
  • 126
    Knippenberg R, Alihonou E, Soucat A, et al. Implementation of the Bamako Initiative; Strategies in Benin and Guinea. Int J Health Plan Manag 1997;12: S29S47.
  • 127
    Soucat A, Levy-Bruhl D, DE Bethune X, et al. Affordability, cost-effectiveness and efficiency of primary health care: the Bamako Initiative experience in Benin and Guinea. Int J Health Plan Manag 1997;12: S81S108.
  • 128
    Knippenberg R, Soucat A, Oyegbite K, et al. Sustainability of primary health care including expanded program of immunizations in Bamako Initiative programs in West Africa: an assessment of 5 years' field experience in Benin and Guinea. Int J Health Plan Manag 1997;12: S9S28.
  • 129
    Diallo I, Molouba R, Sarr LC. Primary health care: from aspiration to achievement. World Health Forum 1993;14: 349355.
  • 130
    Ceesay N, Kalliecharan RV. Sustaining the Bamako Initiative in the Gambia—some management implications. World Hosp Health Serv 1994;30: 1014.
  • 131
    Napoles-Springer A, Perez-Stable EJ. The role of culture and language in determining best practices. J General Intern Med 2001;16: 493495.
  • 132
    Nordberg E. Health and the elderly in developing countries with special reference to sub-Saharan Africa. East Afr Med J 1997;74: 629633.
  • 133
    Kale R. Traditional healers in South Africa: a parallel health care system. BMJ 1995;310: 11821185.
  • 134
    Fassin D, Fassin E. Traditional medicine and the stakes of legitimation in Senegal. Soc Sci Med 1988;27: 353357.
  • 135
    Pretorius E. Traditional and modern medicine working in tandem. Curationis 1991;14: 1013.
  • 136
    Ait-Khaled N, Enarson D. Management of asthma guidelines. Guide for Low Income Countries. IUATLD. Frankfurt am Main, Moskau, Senwald, Wien: pmi-Verl Gruppe, 1996.
  • 137
    Global strategy for asthma management and prevention. http://www.ginasthma.com 2002 (revised 2002).
  • 138
    Unwin N, Mugusi F, Aspray T, et al. Tackling the emerging pandemic of non-communicable diseases in sub-Saharan Africa: the essential NCD health intervention project. Public Health 1999;113: 141146.
  • 139
    Ait-Khaled N, Enarson DA, Behbehani N, Yeung MC, Irisen E. The Asthma Workshop. Report of a workshop organised by the International Union Against Tuberculosis and Lung Disease, Paris, 15–16 December 2000. Int J Tubercul Lung Dis 2001;5: 973977.
  • 140
    Partridge MR, Fabbri LM, Chung KF. Delivering effective asthma care—how do we implement asthma guidelines? Eur Respir J 2000;15: 235237.
  • 141
    Holgate ST, Bousquet J, Chung KF, Bisgaard H, Pauwels R, Fabbri L, et al. Recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma. Group for the Respect of Ethics and Excellence in Science (GREES). Int J Pharm Med 2002;16: 115127.
  • 142
    Pauwels RA, Lofdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999;340: 19481953.
  • 143
    Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000;320: 12971303.
  • 144
    Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000;343: 19021909.
  • 145
    Spencer S, Calverley PM, Sherwood Burge P, Jones PW. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163: 122128.
  • 146
    Ait-Khaled N, Hamadache M, Byles KB. Analysis of demand for pulmonary function testing for obstructive airway disease in an Algerian laboratory. Bull Int Union Tubercul Lung Dis 1990;65: 3941.
  • 147
    Muzembo Ndundu J, Nkakudulu Bikuku H, Frans A. Respiratory rehabilitation in patients with bronchial asthma and chronic obstructive pulmonary disease (COPD) in Kinshasa. Rev Pneumol Clin 2001;57: 209218.
  • 148
    Wilkinson D, Floyd K, Gilks CF. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa. S Afr Med J 2000;90: 794798.
  • 149
    Wijewardene K, Spohr M. An attempt to measure burden of disease using disability adjusted life years for Sri Lanka. Ceylon Med J 2000;45: 110115.
  • 150
    Utzinger J, Tozan Y, Singer BH. Efficacy and cost-effectiveness of environmental management for malaria control. Trop Med Int Health 2001;6: 677687.
  • 151
    Shibuya K. Recent trends in mortality, years of life lost (YLLs), and disability-adjusted life years (DALYs) attributable to tobacco in Japan. Nippon Eiseigaku Zasshi 2001;56: 484491.
  • 152
    Schellenberg D, Menendez C, Kahigwa E, et al. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet 2001;357: 14711477.
  • 153
    Kerry SM, Bland JM. Trials which randomize practices. I. How should they be analysed? Fam Pract 1998;15: 8083.
  • 154
    Kerry SM, Bland JM. Trials which randomize practices. II. Sample size. Fam Pract 1998;15: 8487.
  • 155
    Moudgil H, Honeybourne D. Differences in asthma management between white European and Indian subcontinent ethnic groups living in socioeconomically deprived areas in the Birmingham (UK) conurbation. Thorax 1998;53: 490494.
  • 156
    Kattan M, Mitchell H, Eggleston P, et al. Characteristics of inner-city children with asthma: the National Cooperative Inner-City Asthma Study. Pediatr Pulmonol 1997;24: 253262.
  • 157
    Mitchell H, Senturia Y, Gergen P, et al. Design and methods of the National Cooperative Inner-City Asthma Study. Pediatr Pulmonol 1997;24: 237252.
  • 158
    Kahn JG, Marseille E. Fighting global AIDS. The value of cost-effectiveness analysis. Aids 2000;14: 26092610.
  • 159
    Parent du Chatelet I, Gessner BD, Da Silva A. Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis. Vaccine 2001;19: 34203431.
  • 160
    Maher D, Van Gorkom JL, Gondrie PC, Raviglione M. Community contribution to tuberculosis care in countries with high tuberculosis prevalence: past, present and future. Int J Tubercul Lung Dis 1999;3: 762768.
  • 161
    Nuwaha F. Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa. East Afr Med J 1998;75: 520527.
  • 162
    Goodman CA, Coleman PG, Mills AJ. Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet 1999;354: 378385.
  • 163
    Alonzo Gonzalez M, Menendez C, Font F, et al. Cost-effectiveness of iron supplementation and malaria chemoprophylaxis in the prevention of anaemia and malaria among Tanzanian infants. Bull World Health Org 2000;78: 97107.
  • 164
    Bos JM, Postma MJ. The economics of HIV vaccines: projecting the impact of HIV vaccination of infants in sub-Saharan Africa. Pharmacoeconomics 2001;19: 937946.
  • 165
    Sweat M, Gregorich S, Sangiwa G, et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 2000;356: 113121.
  • 166
    Pobee JO. Community-based high blood pressure programs in sub-Saharan Africa. Ethn Dis 1993;3: S38S45.
  • 167
    Rashid S, Aspray TJ, Edwards R, et al. Essential NCD Health Intervention Project Team. The pitfalls of measuring changes in smoking habits. Trop Doc 2000;30: 160161.
  • 168
    Chan-Yeung M, MacLean L, Paggiaro PL. Follow-up study of 232 patients with occupational asthma caused by western red cedar (Thuja plicata). J Allergy Clin Immunol 1987;79: 792796.
  • 169
    Malo JL, Lemiere C, Desjardins A, Cartier A. Prevalence and intensity of rhinoconjunctivitis in subjects with occupational asthma. Eur Respir J 1997;10: 15131515.
  • 170
    Fox-Rushby JA, Hanson K. Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Plan 2001;16: 326331.
  • 171
    Hollinghurst S, Bevan G, Bowie C. Estimating the ‘avoidable’ burden of disease by Disability Adjusted Life Years (DALYs). Health Care Manag Sci 2000;3: 921.
  • 172
    Peters EJ, Esin RA, Immananagha KK, Siziya S, Osim EE. Lung function status of some Nigerian men and women chronically exposed to fish drying using burning firewood. Cent Afr J Med 1999;45: 119124.
  • 173
    Orie NN. Comparison of normal respiratory function values in young Kenyans with those of other Africans and Caucasians. East Afr Med J 1999;76: 3134.
  • 174
    Hnizdo E, Churchyard G, Dowdeswel R. Lung function prediction equations derived from healthy South African gold miners. Occupat Environ Med 2000;57: 698705.